Evaluation of efficacy and safety of a modified release glucocorticoid in the treatment of moderate to severe active rheumatoid arthritis accompanied by morning stiffness: a randomized, double blind, double dummy, comparative, multi-center study.
Phase of Trial: Phase III
Latest Information Update: 24 Jul 2017
At a glance
- Drugs Prednisolone (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Sun Pharmaceutical Industries
- 18 Jul 2017 Status changed from not yet recruiting to recruiting.
- 29 Aug 2016 New trial record